Tudor Investment Corp
PYXS icon

Tudor Investment Corp’s Pyxis Oncology PYXS Stock Holding History

Tudor Investment Corp’s Portfolio PYXS Stock Details PYXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-13,624
Closed -$55K – 2837
2023
Q1 		$55K Hold
13,624
– – ﹤0.01% 2282
2022
Q4 		$18K Hold
13,624
– – ﹤0.01% 2270
2022
Q3 		$27K Hold
13,624
– – ﹤0.01% 2203
2022
Q2 		$32K Hold
13,624
– – ﹤0.01% 1988
2022
Q1 		$55K Hold
13,624
– – ﹤0.01% 1861
2021
Q4 		$149K Buy
+13,624
New +$156K ﹤0.01% 2205

Other funds holding PYXS

LCM
Laurion Capital Management New York $2.29B AUM 75.73% 1-Year Est. Return
TCM
Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TCM
Tekla Capital Management Boston, Massachusetts $2.56B AUM 18.15% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ECM
ExodusPoint Capital Management New York $12.6B AUM 30.13% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Tudor Investment Corp's PYXS Position: Q2 2023 in Review

Tudor Investment Corp sold out of Pyxis Oncology (PYXS) in Q2 2023, closing a stake of 13,624 shares — an estimated $55K sold.

Tudor Investment Corp first reported a position in PYXS in Q4 2021 and held it in 6 quarters. The position peaked at $149K in Q4 2021. 48 funds tracked by Wall St. Rank hold PYXS as of Q2 2023.

  • Tudor Investment Corp reported no remaining Pyxis Oncology position as of Q2 2023 after selling out during the quarter.
  • Tudor Investment Corp sold 13,624 Pyxis Oncology shares in Q2 2023, an estimated $55K.
  • Tudor Investment Corp first reported a position in Pyxis Oncology in Q4 2021 and held it in 6 quarters.
  • Tudor Investment Corp's Pyxis Oncology position peaked at $149K in Q4 2021.
  • 48 funds tracked by Wall St. Rank held Pyxis Oncology as of Q2 2023.

Based on Tudor Investment Corp's 13F filing for Q2 2023, filed 14 Aug 2023.